State Street’s Mural Oncology MURA Stock Holding History

State Street’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-84,873	Closed	-$176K	–	4331
2025 Q3	$176K	Hold	84,873	–	–	﹤0.01%	3944
2025 Q2	$210K	Buy	84,873 +19,800	+30%	+$46.7K	﹤0.01%	3819
2025 Q1	$82K	Hold	65,073	–	–	﹤0.01%	4011
2024 Q4	$210K	Buy	65,073 +6,060	+10%	+$21.4K	﹤0.01%	3843
2024 Q3	$185K	Sell	59,013 -907	-2%	-$2.95K	﹤0.01%	3837
2024 Q2	$188K	Sell	59,920 -287,233	-83%	-$1.06M	﹤0.01%	3841
2024 Q1	$1.7M	Sell	347,153 -30,433	-8%	-$148K	﹤0.01%	3326
2023 Q4	$2.24M	Buy	+377,586	New	+$1.52M	﹤0.01%	3278

State Street's MURA Position: Q4 2025 in Review

State Street sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 84,873 shares — an estimated $176K sold.

State Street first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $2.24M in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

State Street reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
State Street sold 84,873 Mural Oncology shares in Q4 2025, an estimated $176K.
State Street first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
State Street's Mural Oncology position peaked at $2.24M in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on State Street's 13F filing for Q4 2025, filed 13 Feb 2026.